Back to TMO

ORBIMED ADVISORS LLC → TMO

ORBIMED ADVISORS LLC TMO Position History

Thermo Fisher Scientific Inc. • Healthcare

Quarters held
4
Latest value
$81.3M
Q3 2026
Peak value
$81.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$26.9M
Q1 2026$22.9M
Q2 2026$45.5M
Q3 2026$81.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$81.3M120.4K——
Q2 2026$45.5M90.7K——
Q1 2026$22.9M46.5K——
Q4 2025$26.9M46.5K——

Other funds holding TMO

Other ORBIMED ADVISORS LLC positions

EWTX

EDGEWISE THERAPEUTICS INC

$630.5M
EWTX

EDGEWISE THERAPEUTICS INC

$630.1M
EWTX

EDGEWISE THERAPEUTICS INC

$488.8M
ADRX

ADARX PHARMACEUTICALS INC

$482.7M
EWTX

EDGEWISE THERAPEUTICS INC

$385.1M
ELVN

ENLIVEN THERAPEUTICS INC

$343.9M
LLY

ELI LILLY & CO

$323.7M
ELVN

ENLIVEN THERAPEUTICS INC

$312M